Wordt geladen...
Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model
Metronomic cyclophosphamide (CPA) treatment activates robust innate anti-tumor immunity and induces major regression of large, implanted brain tumor xenografts when administered on an intermittent, every 6-day schedule, but not on a daily low-dose or a maximum-tolerated dose CPA schedule. Here, we u...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4162810/ https://ncbi.nlm.nih.gov/pubmed/25069038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2014.07.033 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|